Prosecution Insights
Last updated: November 16, 2026
Application No. 19/118,751

PORTABLE ELECTROCARDIOGRAM DEVICE

Non-Final OA §101§102§103
Filed
Apr 04, 2025
Priority
Oct 07, 2022 — RE 10-2022-0128444 +1 more
Examiner
BERTRAM, ERIC D
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Ustation Inc.
OA Round
1 (Non-Final)
81%
Grant Probability
Favorable
1-2
OA Rounds
93%
With Interview

Examiner Intelligence

Grants 81% — above average
81%
Career Allowance Rate
1058 granted / 1302 resolved
+11.3% vs TC avg
Moderate +12% lift
Without
With
+12.1%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
51 currently pending
Career history
1352
Total Applications
across all art units

Office Action

§101 §102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Information Disclosure Statement The information disclosure statement (IDS) submitted on 4/4/2025 was filed in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statement is being considered by the examiner. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Section 33(a) of the America Invents Act reads as follows: Notwithstanding any other provision of law, no patent may issue on a claim directed to or encompassing a human organism. Claims 1-7 are rejected under 35 U.S.C. 101 and section 33(a) of the America Invents Act as being directed to or encompassing a human organism. See also Animals - Patentability, 1077 Off. Gaz. Pat. Office 24 (April 21, 1987) (indicating that human organisms are excluded from the scope of patentable subject matter under 35 U.S.C. 101). Claim 1 recites that the electrode is “in contact with a finger.” This is defining that the electrode is always in contact with a finger, and thus the finger is a structural limitation of the claim. The claim should be amended to recite that the electrode is “configured to be in contact” in order to overcome the rejection. Claims 2-7 depend from claim 1. Claims 1-7 are rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea without significantly more. Claim 1 is directed to an apparatus (Step 1 of MPEP 2106). Claim 1 recites a generic control unit configured to acquire signals, detect R signals, normalizing the R signals, extract a signal group and construct an ECG graph. These limitations, as currently drafted, recite a process that covers performance of the limitations in the mind and/or by hand while additionally reciting generic computer components in association with the abstract steps. That is, other than reciting generic computing component language and extra-solution data gathering devices, nothing in the claims preclude the steps from practically being performed in the mind. Specifically, a doctor can receive ECG signals printed out on paper, analyze the information in their mind or on paper to detect R signals, normalize the R signals signals, extract a signal group and construct an ECG graph in their mind or on paper. No tangible therapy or change to the operation of the device itself is claimed. That is, the claims do not require actually doing anything tangible as a result of the construction or even specifically describe specialized circuitry or structures for performing the analysis. If a claim limitation, under its broadest reasonable interpretation, covers performance of the limitation in the mind but for the recitation of generic computer components, then it falls within the “Mental Processes” grouping of abstract ideas. Accordingly, the claim recites an abstract idea (Step 2A in MPEP 2106). This judicial exception is not integrated into a practical application. As described above, the claims do not attempt to apply the abstract idea to deliver a specific treatment to a patient or to change operation of the device itself. In particular, claim 1 merely recites a generic “control unit.” This additional limitation is recited at a high-level of generality (i.e., as a generic component with no details in the claims). The mere fact that a control unit is recited to perform certain tasks does not make the unit "special purpose," based on the Supreme Court's decisions in Alice and Bilski, wherein providing a programmed computer with no further details is insufficient to impart eligibility. The current claims amount to no more than an abstract idea and trying to claim a generic computing device to “apply it." Additionally, data gathering and its generic components have been deemed an “extra-solution activity” that does not amount to an inventive concept when the activity is well-understood and/or conventional (see MPEP 2106.05(g)). In this case, any collection of ECG data using sensors is specifically “pre-solution activity.” MPEP 2105.04(d)(2), section c. clearly states that administration of medical care in order to gather data for a mental step is considered extra-solution activity and does not integrate the judicial exception into a practical application. Accordingly, these additional elements do not integrate the abstract idea into a practical application because it does not impose any meaningful limits on practicing the abstract idea (Step 2B of MPEP 2106). Additionally, invoking computers or other machinery merely as a tool to perform an existing process will generally not amount to significantly more than a judicial exception. See. e.g., Versata Development Group v, SAP America, 793 F.3d 1306, 1335, 115 USPG2d 1681, 1702 (Fed. Cir. 2015) (explaining that in order for a machine to add significantly more, it must “play a significant part in permitting the claimed method to be performed, rather than function solely as an obvious mechanism for permitting a solution to be achieved more quickly"). In this case, as described above, it is possible for the claimed functional language/method steps performed by the “control unit” to be carried out mentally and/or manually. The claim is directed to an abstract idea. The claim does not include additional elements that are sufficient to amount to significantly more than the judicial exception. As discussed above with respect to integration of the abstract idea into a practical application, the additional element of using generic structures to perform certain functional language steps and/or to collect data amounts to no more than mere instructions to apply the exception using a generic computer component or to perform extra-solution activity in a conventional way. Mere instructions to apply an exception using a generic computer component cannot provide an inventive concept. Additionally, a generic control unit that has not been claimed with any specificity is considered by the Examiner to be well-understood, routine and conventional in the art and thus cannot be considered significantly more than the judicial exception. Furthermore, the Examiner takes Official Notice that the control unit broadly and generically disclosed and claimed in the current application is well-understood, routine and conventional in the art for receiving and processing cardiac signals. Therefore, the claim does not include additional elements that are sufficient to amount to significantly more than the judicial exception (Step 2B of MPEP 2106). The “sensor unit” and “display” are recited broadly and generically. In this case, any collection of ECG data using sensors is specifically “pre-solution activity.” MPEP 2105.04(d)(2), section c. clearly states that administration of medical care in order to gather data for a mental step is considered extra-solution activity and does not integrate the judicial exception into a practical application. Furthermore, the Examiner takes Official Notice that the sensor and display are broadly and generically disclosed and claimed in the current application is well-understood, routine and conventional in the art for receiving and processing cardiac signals. Furthermore, the applicant has not shown that the claimed apparatus is necessarily and inextricably rooted in cardiac diagnosis technologies. For example, in DDR Holdings it was found that the claimed subject matter was significantly more because the abstract method was not just applied on/using the internet but it changed how the internet itself worked. In this case, the applicant’s claims do not change the functioning of the recited device. Instead, these generic components are merely being used to apply the abstract idea, as in Alice. While it seems clear that there is not a particular machine required by the claims, it also appears that there is not a particular transformation, either. It has been held that manipulation or signal processing of data to produce new data is NOT a transformation CyberSource v. Retail Decisions, 654 F.3d 1366, 1372 n.2, 99 USPQ2d 1690, 1695 n.2 (Fed. Cir. 2011) (quoting In re Warmerdam, 33 F.3d 1354, 1355, 1360 (Fed. Cir. 1994)). Finally claim 15 is analogous to the case Elec. Power Grp., LLC v. Alstom S.A. (Fed. Cir. 2016) which contains the following analysis: Information as such is an intangible. See Microsoft Corp. v. AT & T Corp., 550 U.S. 437, 451 n.12 (2007). Accordingly, we have treated collecting information, including when limited to particular content (which does not change its character as information), as within the realm of abstract ideas. See, e.g., Internet Patents, 790 F.3d at 1349; OIP Techs., Inc. v. Amazon. com, Inc., 788 F.3d 1359, 1363 (Fed. Cir. 2015). In a similar vein, we have treated analyzing information by steps people go through in their minds, or by mathematical algorithms, without more, as essentially mental processes within the abstract-idea category. See, e.g., TLI Commc’ns, 823 F.3d at 613; Digitech, 758 F.3d at 1351; SmartGene, Inc. v. Advanced Biological Labs., SA, 555 F. App’x 950, 955 (Fed. Cir. 2014); Bancorp Servs., L.L.C. v. Sun Life Assurance Co. of Canada (U.S.), 687 F.3d 1266, 1278 (Fed. Cir. 2012); CyberSource Corp. v. Retail Decisions, Inc., 654 F.3d 1366, 1372 (Fed. Cir. 2011); SiRF Tech., Inc. v. Int’l Trade Comm’n, 601 F.3d 1319, 1333 (Fed. Cir. 2010); see also Mayo, 132 S. Ct. at 1301; Parker v. Flook, 437 U.S. 584, 589–90 (1978); Gottschalk v. Benson, 409 U.S. 63, 67 (1972); Diamond v. Diehr, 450 U.S. 175 (1981). And we have recognized that merely presenting the results of abstract processes of collecting and analyzing information, without more (such as identifying a particular tool for presentation), is abstract as an ancillary part of such collection and analysis. See, e.g., Content Extraction, 776 F.3d at 1347; Ultramercial, Inc. v. Hulu, LLC, 772 F.3d 709, 715 (Fed. Cir. 2014). Here, the claims are clearly focused on the combination of those abstract-idea processes. The advance they purport to make is a process of gathering and analyzing information of a specified content, and not any particular assertedly inventive technology for performing those functions. They are therefore directed to an abstract idea. Applicant should add some sort of active use to the claims, such as applying a SPECIFIC therapy or updating the functioning of the model based on the determination/comparison. Additional case law that supports this analysis include Digitech (Organizing and manipulating information through mathematical correlations), and Grams (An algorithm for calculating parameters indicating an abnormal condition). Therefore, the Examiner must conclude that the independent claim is directed to an abstract idea. Regarding the dependent claims, the recited limitations fall under a mental process using the same rationale as above. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim 1 is rejected under 35 U.S.C. 102(a)(2) as being anticipated by Anderson et al. (US 2024/0074668, hereinafter Anderson). Regarding claim 1, Anderson discloses a sensor unit 110 that is configured to detect an ECG from an electrode in contact with a finger, if so desired by a user (par. 0057). A display 122 is configured to display any and all information, including ECG information if so desired by a user (par. 0059). A control unit 118 is configured to acquire electrode signals through the sensor unit, detect a plurality of R signals (see fig. 3 and 5), generate a normalized signal obtained by rearranging the cycles of the R signals (fig. 5-6) extracting a signal group belonging to a normal category based on the integral (i.e., necessary) values on the normalized dataset and constructing an ECG graph that could be displayed if so desired by a user (see fig. 4). Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 4-6 are rejected under 35 U.S.C. 103 as being unpatentable over Anderson in view of Cho et al. (US 2013/0296723, hereinafter Cho). Anderson discloses the applicant’s basic invention but is silent as to blocking or utilizing measurements based on detected motion of a user. Cho discloses an ECG measurement device and thus is analogous art with Anderson. Specifically, based on detected motion signals, Cho will only sense ECG signals when motion signals are below a threshold (claims 1 and 2). Therefore, it would have been obvious to one of ordinary skill in the are before the applicant’s effective filing date to modify Anderson to only sense ECG signals when motion signals are below a threshold as taught by Cho in order to ensure accuracy of the measurement (par. 0009 for motivation). Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. See attached PTO-892. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Eric D Bertram whose telephone number is (571)272-3446. The examiner can normally be reached Monday-Friday 8am-6pm Central Time. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer McDonald can be reached at 571-270-3061. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Eric D. Bertram/Primary Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

Apr 04, 2025
Application Filed
Aug 19, 2026
Non-Final Rejection mailed — §101, §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12788980
NANOSECOND PULSED ELECTRIC FIELD SYSTEM
2y 9m to grant Granted Nov 10, 2026
Patent 12788296
Wearable Multi-Modal Sensing Device for Real-Time Neurological Monitoring and Disorder Detection
1y 10m to grant Granted Nov 10, 2026
Patent 12779235
WEARABLE CARDIOVERTER DEFIBRILLATOR (WCD) SYSTEM REACTING TO HIGH-AMPLITUDE ECG NOISE
3y 6m to grant Granted Nov 03, 2026
Patent 12773565
IMPLANTABLE MEDICAL DEVICES FOR MULTI-CHAMBER PACING
3y 5m to grant Granted Oct 27, 2026
Patent 12773153
METHOD FOR OBTAINING AN ELECTROCARDIOGRAM IN PRONATED SUBJECTS
1y 11m to grant Granted Oct 27, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
81%
Grant Probability
93%
With Interview (+12.1%)
Low
PTA Risk
Based on 1302 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month